GEN PLUS    Pharma Innovation for the next Generation

Well established processes in the daily business of physicians, pharmacies, wholesalers, the pharmaceutical industry and health insurances become more and mo...

Again Gen-Plus, like last year, attended the world´s largest Pharma event, the CPhI worldwide. As a guest at the Midas stand (our warmest thank you for the c...

This is the motto that brings together clients and personnel of Gen-Plus annually to enjoy a day of discussion, exchange and networking. The entire company t...

Striving continuously to expand competencies and services Gen-Plus accomplished another milestone. Effective immediately we are now able to offer clinical tr...

Gen-Plus really had a great year so far, actually its best after the MBO 2015. Since then we managed a full turnaround from an internal development service t...

Gen-Plus finishes successfully the re-qualification of its PML-installation for any types of drug products based on film technology like Oral Dispersible Fil...

The 2 companies Gen-Plus and DiHeSys – Digital Health Systems conducted their second workshop on precision medicine on 19./20. June in Munich. Due to its rel...

Formulations utilizing high-potent APIs is one of the Gen-Plus key competencies. Over 60 drug products of cytostatics, immunosuppressives and kinase inhibito...

On November 1st, 2016, the project entitled “Osmoprotective Antibiotic Ionic Liquids” which isfunded by the Bayerische Forschungsstiftung started with a kick...

On October 20th, the second Science Day “Novel technologies” was held at the facilities of Gen- Plus. This event covered a wide range from novel technologies...

In the field of pharmaceutical and technological development digital microscopy is showing in many fields decisive improvements compared to the optical micro...

As in the previous year, Gen-Plus invited to the Come & See Day in Munich. This year´s lecture series was opened by Prof. Dr. Dr. Lorenz Meinel, from the Ins...

The pharmaceutical market is expected to rearrange in the coming years. In the future it will not be sufficient for pharmaceutical companies only to develop,...

Risk assessment of new projects is a difficult and complex matter. The Monte Carlo method is becoming a powerful tool to get ahandle on risk assessment by ca...

Das User Forum Skin Permeation richtet sich an interessierte Anwender, die bereits Erfahrungen auf dem Gebiet der in vitro Haut-Permeation gemacht haben oder...

Due to the increasing demand, we have invested in new storage cabinets. Overall, we own now 6 storage cabinets with a capacity of each between 240 and 720 li...

In Munich it was the Oktoberfest time and Gen-Plus invited costumers to their first “Come & See day”. At the opening ceremony the female staff, dressed in da...

On 17th and 18th September 2015 Ms Dr. Wanninger und Mr. Rappl from GMP inspectorate of the "Regierung von Oberbayern" performed a GMP inspection at Gen-Plus...

Dr. Markus Dachtler is managing director since 1 June 2015. The young entrepreneur Dr. Dachtler has many years of experience in pharmaceutical business. He h...